UBA7 Antikörper
-
- Target Alle UBA7 Antikörper anzeigen
- UBA7 (Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser UBA7 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Fusion protein of human UBA7
- Isotyp
- IgG
- Top Product
- Discover our top product UBA7 Primärantikörper
-
anti-Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7) (AA 1-1012) antibody
UBA7 Reaktivität: Human WB, IF, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7) (C-Term) antibodyUBA7 Reaktivität: Human WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7) (C-Term) antibodyUBA7 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7) (AA 1-1012) antibodyUBA7 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7) antibodyUBA7 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 5B10 unconjugated
anti-Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7) (N-Term) antibodyUBA7 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7) (AA 1-1012) antibodyUBA7 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7) (AA 23-238) antibodyUBA7 Reaktivität: Maus WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7) (AA 249-517) antibodyUBA7 Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7) (AA 963-1012) antibodyUBA7 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC 1:30-1:150, ELISA 1:5000-1:10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.6 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- UBA7 (Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7))
- Andere Bezeichnung
- UBA7 (UBA7 Produkte)
- Synonyme
- D8 antikoerper, UBA1B antikoerper, UBE1L antikoerper, UBE2 antikoerper, Ube1l antikoerper, 1300004C08Rik antikoerper, UBE1 antikoerper, xubc3 antikoerper, ubiquitin like modifier activating enzyme 7 antikoerper, ubiquitin-like modifier activating enzyme 7 antikoerper, ubiquitin conjugating enzyme E2 R2 S homeolog antikoerper, ubiquitin-like modifier-activating enzyme 7 antikoerper, UBA7 antikoerper, Uba7 antikoerper, ube2r2.S antikoerper, LOC100092397 antikoerper
- Hintergrund
- The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E1 ubiquitin-activating enzyme family. The encoded enzyme is a retinoid target that triggers promyelocytic leukemia (PML)/retinoic acid receptor alpha (RARalpha) degradation and apoptosis in acute promyelocytic leukemia, where it is involved in the conjugation of the ubiquitin-like interferon-stimulated gene 15 protein.
- UniProt
- P41226
-
